Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children
Clinical trial NCT03868852 · UNKNOWN
Trial details
- NCT number
- NCT03868852
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.